Status:

TERMINATED

Effects of Fenofibrate on Metabolic and Reproductive Parameters in Polycystic Ovary Syndrome

Lead Sponsor:

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Conditions:

Polycystic Ovary Syndrome

Eligibility:

FEMALE

18-45 years

Phase:

NA

Brief Summary

This is a prospective randomized, double-blind placebo-controlled trial of 6 months' duration evaluating the effect of fenofibrate (200 mg/day) in females with polycystic ovary syndrome and mild hyper...

Eligibility Criteria

Inclusion

  • premenopausal women ≥ 18 years
  • diagnosis of PCOS based on the recent 2006 Androgen Excess Society criteria (modified from Rotterdam 2003)
  • waist circumference \>88 cm
  • fasting TG 2.0 - 5.0 mmol/L
  • stable on any type of oral contraceptive for a minimum of 3-months

Exclusion

  • known contraindications for MRI
  • pregnancy, lactation, desire to become pregnant
  • participation in another clinical trial
  • fasting TF level ≥ 5.0 mmol/L
  • AST or ALT \> 2.5 times upper limit of normal (ULN)
  • creatinine kinase (CK) \> 6x ULN
  • creatinine \> 115 μmol/L
  • fasting glucose ≥ 7.0 mmol/L and/or 2h glucose post oral glucose tolerance test (OGTT) ≥ 11.1 mmol/L or personal history of DM2
  • personal history of renal disease, liver disease (except NAFLD), or heart disease
  • body mass index (BMI) \< 18 or \> 40 kg/m²
  • increased alcohol use (\>9 standard drinks per week \[standard drink = 12oz beer, 5oz wine, or 1.5oz spirits\]) or drug use
  • use of other hormonal contraception, growth hormone, glucocorticoids, anti-diabetic/anti-dyslipidemia medications, or anabolic steroids.

Key Trial Info

Start Date :

December 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2015

Estimated Enrollment :

4 Patients enrolled

Trial Details

Trial ID

NCT00884819

Start Date

December 1 2008

End Date

February 1 2015

Last Update

April 3 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

St. Joseph's Health Care

London, Ontario, Canada, N6A 4L6